The family of a man who died from prostate cancer after care failings led to a nine-year delay in diagnosis have described ...
Only about 6% of men have had a documented discussion with their primary care doctor about prostate cancer screening, even ...
Lupin secures tentative USFDA nod for generic Enzalutamide tablets, paving the way for future entry into the prostate cancer ...
When high-profile figures publicly discuss their prostate cancer, the public health impact can be immediate. The media ...
A new blood test may make it easier to detect the most dangerous forms of prostate cancer early. In a study from Karolinska ...
The major challenge in prostate cancer screening is not just to find more cancer cases, but to identify the cancers that are ...
Mumbai-based Lupin Ltd has secured tentative US FDA approval for Enzalutamide Tablets in multiple strengths, offering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results